Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

New study reveals where hedge funds are most over exposed

Tuesday, November 19, 2013

Beverly Chandler, Opalesque London:

eVestment, an institutional investment data and analytics firm, has issued a report entitled "Hedge Fund Exposure & Tail Risk," which aggregates the positions of the 30 largest hedge funds and quantifies their market exposures, risks, expected returns and performance in stressed market environments. eVestment says that the results show where these funds are overexposed and most vulnerable to large losses through Q3 2013.

The key findings show:

  • The 30 hedge funds controlling over a third of a trillion US dollars are, in aggregate, bullish on medium grade (BBB/BB) US corporate debt, US fixed rate asset backed securities, global high grade (AAA) corporate debt and US equities with a bias towards large cap and growth characteristics.
  • An asset-weighted portfolio comprised of the 30 largest hedge funds is expected to return on average 0.73% over the next month, and in the best case scenario 3.10%, according to its Expected Tail Return (ETR) at a 95% confidence level.
  • Of 11 historical stress test scenarios, a repeat of the 2000 burst of the dot-com tech bubble and the ensuing NASDAQ market crash presents the largest risk of loss for the asset-weighted portfolio of the 30 largest hedge funds. Despite the downward pressure if a similar event were to occur, the portfolio’s negative return expectation is limited to -2.29%.
  • A recurrence of the global market volat......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner